In this video interview, Adrianne Rivard, senior community development manager at myTomorrows, explains why compliance with ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

Results from a Phase II trial (NCT06449209) showed that BioNTech’s and Bristol Myers Squibb’s pumitamig in combination with ...

In this video interview, Adrianne Rivard, senior community development manager at myTomorrows, highlights how combining AI ...

Results from the Phase III ASCEND trial (NCT05882877) showed rocatinlimab maintained long-term efficacy with a favorable ...

Five-year results from the Phase III EMPOWER-Lung 3 trial show Libtayo combined with chemotherapy achieved a 19.4% overall ...

Results from the Phase III FLAUR2 trial (NCT04035486) showed that Tagrisso combined with pemetrexed and platinum-based ...

In this video interview, Adrianne Rivard, senior community development manager at myTomorrows, explains why unified, ...

Positive Overall Survival (OS) Trend: Ivonescimab plus chemotherapy showed a favorable OS trend in EGFR-mutated NSCLC, with ...

Comirnaty's Phase III trial showed robust immune responses in higher-risk adults, with a significant increase in neutralizing ...

In this episode of the Applied Clinical Trials Brief, we recap our three most-viewed articles of the week—spotlighting Veeva ...

Aligning artificial intelligence with patient needs, trial workflows, and employee experience enables adoption, builds trust, ...